SIC 3845 – Electromedical and Electrotherapeutic Apparatus
| Valuation | |
|---|---|
| Market Cap ($M) | 135.98 |
| Enterprise Value ($M) | 197.58 |
| Book Value ($M) | 122.89 |
| Book Value / Share | 2.38 |
| Price / Book | 1.11 |
| NCAV ($M) | 100.30 |
| NCAV / Share | 1.94 |
| Price / NCAV | 1.36 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.67 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -0.80 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.37 |
| Current Ratio | 5.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 291.22 |
| Assets | 313.80 |
| Liabilities | 190.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 130.38 |
| Operating Income | -169.77 |
| Net Income | -172.80 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -131.37 |
| Cash from Investing | 83.03 |
| Cash from Financing | 43.65 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ameriprise Financial Inc | 10.12 | 71.41 | |
| 13G | T. Rowe Price Investment Management, Inc. | 6.30 | -10.03 | |
| 13G/A | Bellevue Group AG | 3.50 | -38.10 | |
| 13G/A | Vanguard Group Inc | 7.85 | -13.94 | |
| 13G | Morgan Stanley | 6.80 | ||
| 13G/A | Fmr Llc | 14.07 | -2.48 | |
| 13G/A | BlackRock Inc. | 7.60 | 8.44 | |
| 13G/A | Jpmorgan Chase & Co | 9.40 | -5.24 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 82,333 | 217,992 | 37.77 | |
| 132,385 | 329,914 | 40.13 | |
| 101,873 | 105,036 | 96.99 | |
| 195,695 | 234,925 | 83.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NARI – Inari Medical, Inc. | NVCR – NovoCure Limited |
| OFIX – Orthofix Medical Inc. | OSUR – OraSure Technologies, Inc. |
| PODD – Insulet Corporation |
Financial data and stock pages provided by
Fintel.io